Compare YORW & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | YORW | EOLS |
|---|---|---|
| Founded | 1816 | 2012 |
| Country | United States | United States |
| Employees | 104 | N/A |
| Industry | Water Supply | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 552.3M | 550.9M |
| IPO Year | 1994 | 2018 |
| Metric | YORW | EOLS |
|---|---|---|
| Price | $34.38 | $9.02 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $34.00 | $15.50 |
| AVG Volume (30 Days) | 108.4K | ★ 969.9K |
| Earning Date | 05-12-2026 | 05-04-2026 |
| Dividend Yield | ★ 3.13% | N/A |
| EPS Growth | N/A | ★ 1.23 |
| EPS | ★ 0.82 | N/A |
| Revenue | $77,488,000.00 | ★ $297,176,000.00 |
| Revenue This Year | $11.78 | $13.27 |
| Revenue Next Year | $4.95 | $17.62 |
| P/E Ratio | $42.17 | ★ N/A |
| Revenue Growth | 3.37 | ★ 11.61 |
| 52 Week Low | $28.26 | $3.86 |
| 52 Week High | $34.81 | $8.82 |
| Indicator | YORW | EOLS |
|---|---|---|
| Relative Strength Index (RSI) | 67.21 | 71.18 |
| Support Level | $30.97 | $5.78 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.68 | 0.46 |
| MACD | 0.17 | 0.11 |
| Stochastic Oscillator | 80.52 | 100.00 |
The York Water Co is the investor-owned water utility in the United States. The primary business of the company is to impound, purify to meet or exceed safe drinking water standards and distribute water. The company also owns and operates three wastewater collection systems and twelve wastewater collection and treatment systems. The company operates within its franchised water and wastewater territory, which covers portions of municipalities within four counties in south-central Pennsylvania. It provides services to diversified, manufacturing such items as fixtures and furniture, electrical machinery, food products, paper, ordnance units, textile products, air conditioning systems, laundry detergent, barbells, and motorcycles.
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.